恶性淋巴瘤的综合治疗石远凯.pptVIP

Optimum Chemotherapy for Favorable StageⅠ - Ⅱ HL Regimens No. of pts outcome 5-year DFS 5-year OS A: VBM x 6 35 88% 94% +regional RT(36Gy) B: STLI(s)/TLI(s) 43 93% 98% (30-40Gy, boost 40-44Gy) P=0.60 P= 0.56 Eligibility :CS ⅠA - ⅡA or CS ⅠB - ⅡB with